2019-07-02 |
Moberg Pharma AB |
Peter Wolpert |
Styrelseledamot/suppleant |
|
Teckning |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
32 620 |
Antal |
59,50 |
SEK |
|
Anmälan
|
2019-07-02 |
Moberg Pharma AB |
Peter Wolpert |
Styrelseledamot/suppleant |
|
Avyttring |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
32 620 |
Antal |
66,6722 |
SEK |
|
Anmälan
|
2019-07-02 |
Moberg Pharma AB |
Anna Helena Constance Ljung |
VD |
|
Teckning |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
40 000 |
Antal |
42,97 |
SEK |
|
Anmälan
|
2019-07-02 |
Moberg Pharma AB |
Anna Helena Constance Ljung |
VD |
|
Avyttring |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
40 000 |
Antal |
66,6722 |
SEK |
|
Anmälan
|
2019-07-01 |
Moberg Pharma AB |
Torbjörn Wärnheim |
SVP R&D |
|
Förvärv |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
7 500 |
Antal |
42,97 |
SEK |
|
Anmälan
|
2019-07-01 |
Moberg Pharma AB |
Torbjörn Wärnheim |
SVP R&D |
|
Avyttring |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
7 500 |
Antal |
66,6722 |
SEK |
|
Anmälan
|
2019-06-29 |
Moberg Pharma AB |
Annika Christine Magnusson |
Senior Director Regulatory Affairs |
|
Teckning |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
15 000 |
Antal |
42,97 |
SEK |
|
Anmälan
|
2019-06-29 |
Moberg Pharma AB |
Annika Christine Magnusson |
Senior Director Regulatory Affairs |
|
Avyttring |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
15 000 |
Antal |
66,6722 |
SEK |
|
Anmälan
|
2019-06-29 |
Moberg Pharma AB |
Annika Christine Magnusson |
Senior Director Regulatory Affairs |
|
Teckning |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
6 227 |
Antal |
59,50 |
SEK |
|
Anmälan
|
2019-06-29 |
Moberg Pharma AB |
Annika Christine Magnusson |
Senior Director Regulatory Affairs |
|
Avyttring |
Moberg Pharma AB |
Aktie |
SE0003613090 |
2019-06-28 |
6 227 |
Antal |
66,6722 |
SEK |
|
Anmälan
|